Geert Cauwenbergh
2017
In 2017, Geert Cauwenbergh earned a total compensation of $422.5K as President, Chief Executive Officer and acting Chief Financial Officer at RXi Pharmaceuticals, a 34% decrease compared to previous year.
Compensation breakdown
| Option Awards | $5,928 |
|---|---|
| Salary | $416,000 |
| Other | $599 |
| Total | $422,527 |
Cauwenbergh received $416K in salary, accounting for 98% of the total pay in 2017.
Cauwenbergh also received $5.9K in option awards and $599 in other compensation.
Rankings
In 2017, Geert Cauwenbergh's compensation ranked 12,441st out of 14,666 executives tracked by ExecPay. In other words, Cauwenbergh earned more than 15.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,441 out of 14,666 | 15th |
Division Manufacturing | 4,895 out of 5,772 | 15th |
Major group Chemicals And Allied Products | 1,793 out of 2,075 | 14th |
Industry group Drugs | 1,491 out of 1,731 | 14th |
Industry Pharmaceutical Preparations | 1,154 out of 1,333 | 13th |
Source: SEC filing on April 26, 2018.
Cauwenbergh's colleagues
We found three more compensation records of executives who worked with Geert Cauwenbergh at RXi Pharmaceuticals in 2017.